- Home
- ICLR vs KNSL Comparison
ICLR vs KNSL Comparison
Compare ICLR & KNSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- KNSL
- Stock Information
- Founded
- ICLR 1990
- KNSL 2009
- Country
- ICLR Ireland
- KNSL United States
- Employees
- ICLR N/A
- KNSL N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- KNSL Property-Casualty Insurers
- Sector
- ICLR Health Care
- KNSL Finance
- Exchange
- ICLR Nasdaq
- KNSL Nasdaq
- Market Cap
- ICLR 11.6B
- KNSL 11.0B
- IPO Year
- ICLR 1998
- KNSL 2016
- Fundamental
- Price
- ICLR $150.41
- KNSL $486.88
- Analyst Decision
- ICLR Buy
- KNSL Buy
- Analyst Count
- ICLR 12
- KNSL 10
- Target Price
- ICLR $187.82
- KNSL $491.88
- AVG Volume (30 Days)
- ICLR 1.1M
- KNSL 227.0K
- Earning Date
- ICLR 07-23-2025
- KNSL 07-24-2025
- Dividend Yield
- ICLR N/A
- KNSL 0.14%
- EPS Growth
- ICLR 11.53
- KNSL 15.35
- EPS
- ICLR 9.19
- KNSL 17.37
- Revenue
- ICLR $8,192,621,999.00
- KNSL $1,638,131,000.00
- Revenue This Year
- ICLR N/A
- KNSL $12.94
- Revenue Next Year
- ICLR $2.10
- KNSL $12.99
- P/E Ratio
- ICLR $16.55
- KNSL $27.62
- Revenue Growth
- ICLR N/A
- KNSL 22.79
- 52 Week Low
- ICLR $125.10
- KNSL $366.92
- 52 Week High
- ICLR $347.72
- KNSL $531.79
- Technical
- Relative Strength Index (RSI)
- ICLR 57.67
- KNSL 57.87
- Support Level
- ICLR $146.56
- KNSL $481.50
- Resistance Level
- ICLR $155.90
- KNSL $492.15
- Average True Range (ATR)
- ICLR 4.88
- KNSL 10.86
- MACD
- ICLR 0.23
- KNSL 1.19
- Stochastic Oscillator
- ICLR 57.80
- KNSL 80.53
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About KNSL Kinsale Capital Group Inc.
Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.